CXCL10 and cancer: Using immunologically »warm« murine syngeneic colon cancer models, CT26 and MC38, they demonstrated that overexpression of K17 in colon cancer cells was positively correlated with CXCL10 expression by cancer cells, T cell infiltration, and response to check point blockade therapy [66].